By Anthony Bell
Considering recent stages of the world’s development, modern technology creates new threats emerging from developing biological technologies and outlines existing ones.
Global division between already developed and developing countries is exacerbated; the gap between privileged and underprivileged social strata has also widened. Humanity got rid of pandemics like plague and smallpox. However, at the same time, due to the development of modern biological technologies, advanced biothreats have emerged.
The aforementioned biological threats are of the uttermost danger to, first of all, developing – and even some already developed – states of both Africa and Asia. Creation of biological laboratories, the activities of which is, at least, non-transparent may pose some biothreats to these nations.
These laboratories are typically established by the United States of America. However, some Western European states also invest in the development of some sophisticated biological programs with non-declared targets abroad, far from their national territories. Within this context, specific attention is paid to Africa. In recent months, Cameroon, Uganda, Nigeria, Sierra Leone and the Democratic Republic of Congo (DRC) have fallen into the category of countries posing interest to the U.S. in terms of biological activities. The Defense Threat Reduction Agency (DTRA), the State Department and the National Security Agency are known to have ordered and funded some biological programs in these African states. However, sometimes there is a stark discrepancy between stated goals and practical results of those activities. For instance, for a long period of time several U.S. state bodies have been running a program to reduce acquired immunodeficiency syndrome (or AIDS) threats in Nigeria. However, one could question the effectiveness of this program: despite annual increases in its financing (it is known to have amounted to more than USD100 million), the AIDS morbidity level has shown almost no positive changes since 2009. Several public organizations, which protest global biological activities despite their origins, claim that the death rate of AIDS-infected persons in Nigeria has even grown – however, this information should be thoroughly checked. At the same time, the number of Nigerian consumers of medical drugs and medications produced by the U.S.-based Gilead Sciences Incorporated has gradually increased since the beginning of the financing of the aforementioned biological program and reached some 50-60% of all registered patients in Nigeria. Therefore, one could suggest that Nigeria might be used as a kind of ‘biotest range’, as even increased financing of the U.S. biological program has brought no positive effect up to date.
The U.S. is also known to have conducted biological monitoring in the areas of Iraq and Afghanistan adjacent to these countries’ borders with the People’s Republic of China, Turkey, Pakistan and the Kingdom of Saudi Arabia. The tasks to conduct such monitoring have been set, and their results are not public – or, at least, it is not known. The U.S. also expands the presence of its biolabs in the Middle East (namely, Iraq and Jordan), South-East Asia (Indonesia and the Philippines) and Africa (Kenya, Morocco and Uganda).
Since the early 2000s, the U.S. efforts to establish new biological laboratories have been focused on Africa and Asia as well. The U.S. Department of Defense, DTRA, the State Department and NSA have intensified the biological activities of their vendors in the Republic of South Africa, complementing biological activities in DRC, Uganda, Cameroon and Sierra Leone.
The U.S. bio activities also have a footprint in Asia. A U.S. State-Department-run biological program in Afghanistan envisaged the research of the agents of highly contagious and infectious diseases, including tularemia, anthrax and aphtha. The program also stipulated the collection of biological samples in the country and transfer of them to the U.S. A leak of any biological agent in Afghanistan might have provoked a pandemic of at least regional scale as countries like India and Bangladesh feature large population.
Another weak point of this very network might be Pakistan. The U.S. rates Pakistan as compliant with the main principles of the Biological and Toxin Weapons Convention (BTWC). However, according to the Klaxon.com news outlet citing multiple intelligence reports, Pakistan and China covertly signed a three-year agreement to conduct deep research of potentially contagious biological agents. There is not a shred of evidence of both countries having inked such a deal. The Klaxon states that Pakistan and China are playing with anthrax-like pathogens, with the former’s Defense Science and Technology Organization (a part of the Pakistani military) responsible for researches from the Pakistani side.
In Pakistan, the dangerous activities of the Pentagon and the Bill and Melinda Gates Foundation have intensified, which aims to create drugs under the guise of a vaccine intended for forced population control. Back in 2010, the founder of Microsoft called for the use of vaccinations that negatively affect the reproductive function of the body to reduce the population of the Earth. The polio vaccine promoted by the Americans is considered one of these drugs.
The Gates Foundation chose Pakistan as a testing ground for the vaccine. The goal of the current campaign is to test a vaccine with a prolonged negative effect, which makes it impossible to identify the real causes of infertility and diseases of the nervous system in those vaccinated at an older age.
The Americans were not stopped by the scandal of past years, when in India alone more than 47.5 thousand children suffered from the side effects of the polio drug by 2012 (as per independent private news website reports).
Gates directly links the provision of free vaccines to Pakistan with the expansion of cooperation between Islamabad and Washington promoted by the Pentagon in the field of research of dangerous pathogens. After his visit to Pakistan in February 2022, Bill Gates says polio eradication is possible in a few years and the authorities of the Islamic Republic approved the construction of a high-security BSL-3 biological laboratory with the assistance of USAID. This facility is necessary for the Pentagon to increase the effectiveness of the bio-agents being developed, including taking into account their practical testing directly in the host country. With the launch of the laboratory, security threats to India and the entire region will increase sharply.
The Narendra Modi government, unlike Islamabad, addressed security threats in a timely manner and in 2017, after the vaccine scandal, terminated relations with the Gates Foundation.
Therefore, our world might become a dangerous place, where one could barely live in safety.
The author is an independent military analyst.
Disclaimer: Views expressed are personal and do not reflect the official position or policy of Financial Express Online. Reproducing this content without permission is prohibited.